featured
Disease Progression of Metastatic Melanoma on Nivolumab Monotherapy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Peter Kamen
ipi and nivo or try a nivo and lag3 phase 3 trial
Galina Kharkevich
No information on BRAF status. Ipi+Nivo. If BRAFpositive BRAF/MEKi is also possible
Mikhail Abramov
use of combination BRAFi + MEKi possible
Rosane JohnsaoJohnsson n
ipi and nivo clinical trial if possible inhibitor BRAF and MEK